ARCHIVES

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 20 | May 22, 2009

Download PDF Visit The Full Archive

Related Articles

Fraumeni Appointed field Studies Chief

January 18, 1980

Duke, M.D. Anderson Receive Bristol-Myers Unrestricted Grants

May 5, 1989

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

In Brief: HHS Rejects Sole Source Award For Utah Study; Reagan Proclaims April Cancer Control Month

April 3, 1981

In Brief: Lasker Awards; Blobel, Metcalf, Wexler, Rogers; Borch Named Center Director

October 1, 1993

House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding

July 2, 1993